Novo Nordisk threatens legal action against Hims & Hers for “duping” public with cheap compounds of its popular weight-loss drugs

BY KEVIN HAYNES, NEWS WRITER

The logo of Danish pharmaceutical company Novo Nordisk is pictured at their headquarters in Bagsvaerd outside of Copenhagen, Denmark on February 1, 2017, the day before they release their yearly financial results. (Photo by Liselotte Sabroe / Scanpix Denmark / AFP) / Denmark OUT (Photo by LISELOTTE SABROE/Scanpix Denmark/AFP via Getty Images)

Update: Hims & Hers Suddenly Pulls Its $49 Wegovy Copycat After FDA Threatens Action

The manufacturer of two GLP-1 weight-loss drugs, Ozempic and Wegovy, is up in arms over the recent introduction of a $49 alternative pill by the telehealth company Hims & Hers.

Denmark’s Novo Nordisk said Thursday it will pursue legal and regulatory action “to........

© Inc.com